Monte Winslow, PhD – Molecular Determinants of Lung Cancer Growth and Metastasis
September 19 at 1:30 pm - 2:30 pm
Monte Winslow, PhD
Associate Professor, Department of Genetics
Stanford University School of Medicine
Dr. Winslow grew up in Canada and received his undergraduate degree from the University of Victoria, Canada. He did his PhD studies in Immunology working with Dr. Jerry Crabtree at Stanford University before pursuing is postdoctoral training with Dr. Tyler Jacks at MIT.
Dr. Winslow’s research focuses on understanding the mechanisms that drive cancer development, progression, metastasis, and therapy response. He has developed in vivo mouse models to enable the isolation and genomic characterization of cancer cell and used these models to make important contribution to our understanding cancer initiation, growth, and progression. These studies have focused on uncovering the molecular forces that contribute to the development and progression of three of the most metastatic and deadly cancer type: lung adenocarcinoma, small cell lung cancer, and pancreatic cancer. He has also made significant contributions to the development of novel cancer modeling approaches that enable rapid and quantitative analyses of the genetic drivers of carcinogenesis. His laboratory has generated methods for somatic CRISPR/Cas9-mediated genome editing and used these models to induce both gain- and loss-of-function alterations in cells in vivo. By incorporating increasingly quantitative methods and powerful in vivo methods, Dr. Winslow’s work is uncovering general rules that govern tumor growth and progression across diverse tumor genotypes.
Dr. Winslow received young investigator awards from The Baxter Foundation, The Pancreatic Cancer Action Network, and The V Foundation for Cancer Research. His work has been supported by the National Institutes of Health, the Department of Defense, and several foundations.